Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Nuvectis Pharma, Inc. | NVCT | $24.49 | $799.45M | — | |
| Pharming Group N.V. | PHAR | $11.23 | $794.84M | 80.2 | — |
| Monopar Therapeutics Inc. | MNPR | $117.56 | $789.08M | — | |
| Aura Biosciences, Inc. | AURA | $7.56 | $784.01M | — | |
| First Tracks Biotherapeutics Inc | TRAXV | $17.06 May 26, 2026 | $782.20M | — | — |
| Varex Imaging Corporation | VREX | $18.51 | $780.16M | 34.9 | — |
| AgomAb Therapeutics NV | AGMB | $15.78 | $777.13M | — | |
| Crescent Biopharma, Inc. | CBIO | $20.88 | $775.63M | — | |
| Neurogene Inc. | NGNE | $38.60 | $772.44M | — | |
| Phathom Pharmaceuticals, Inc. | PHAT | $9.50 | $768.56M | — | |
| Assembly Biosciences, Inc. | ASMB | $36.60 | $745.20M | 29.3 | — |
| Verastem, Inc. | VSTM | $8.20 | $742.62M | — | |
| Zevra Therapeutics, Inc. | ZVRA | $12.40 | $736.36M | 13.3 | — |
| Collegium Pharmaceutical, Inc. | COLL | $23.53 | $729.41M | 18.5 | — |
| Gyre Therapeutics, Inc. | GYRE | $6.86 | $727.39M | — | |
| GMR Solutions Inc. | GMRS | $13.46 | $727.13M | — | |
| Akso Health Group | AHG | $0.85 | $726.49M | — | |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | $8.98 | $719.96M | — | |
| Astria Therapeutics, Inc. | ATXS | $12.58 Jan 23, 2026 | $718.13M | — | |
| XOMA Royalty Corp | XOMA | $40.17 Jul 21, 2026 | $710.16M | 25.6 | — |
| Enhabit Inc | EHAB | $13.80 May 14, 2026 | $706.91M | — | |
| Ironwood Pharmaceuticals, Inc. | IRWD | $4.26 | $703.92M | 5.4 | — |
| SOPHiA GENETICS SA | SOPH | $8.09 | $688.68M | — | |
| SS Innovations International, Inc. | SSII | $3.41 | $683.31M | — | |
| Shattuck Labs, Inc. | STTK | $6.79 | $681.47M | — | |
| Allogene Therapeutics, Inc. | ALLO | $1.97 | $680.62M | — | |
| Sagimet Biosciences Inc. | SGMT | $10.94 | $680.02M | — | |
| Phreesia, Inc. | PHR | $10.94 | $679.06M | 60.8 | — |
| Oculis Holding AG | OCS | $12.17 | $675.78M | — | |
| Prime Medicine, Inc. | PRME | $3.70 | $671.09M | — | |
| Aquestive Therapeutics, Inc. | AQST | $5.34 | $670.23M | — | |
| MiMedx Group, Inc. | MDXG | $4.57 | $666.13M | 114.3 | — |
| Altimmune, Inc. | ALT | $3.42 | $665.25M | — | |
| Evotec SE | EVO | $1.86 | $661.02M | — | |
| CorMedix Inc. | CRMD | $8.43 | $657.07M | 3.9 | — |
| Valneva SE | VALN | $6.89 | $653.33M | — | |
| Claritev Corporation | CTEV | $38.43 | $651.29M | — | |
| Canopy Growth Corporation | WEED.TO | CA$1.35 | CA$642.01M | — | |
| BlossomHill Therapeutics, Inc. | BLSM | $22.01 | $640.08M | — | |
| Bright Minds Biosciences Inc. | DRUG | $65.16 | $639.35M | — | |
| MapLight Therapeutics, Inc. | MPLT | $13.77 | $638.62M | — | |
| OmniAb, Inc. | OABI | $4.33 | $629.54M | — | |
| Contineum Therapeutics, Inc. | CTNM | $16.70 | $628.27M | — | |
| AngioDynamics, Inc. | ANGO | $15.20 | $628.25M | — | |
| kneat.com Inc | KSI.TO | CA$6.50 Aug 13, 2026 | CA$627.72M | — | |
| Tilray Brands, Inc. | TLRY | $4.50 | $619.11M | — | |
| Evolus, Inc. | EOLS | $9.30 | $614.27M | — | |
| Cytek Biosciences, Inc. | CTKB | $4.70 | $610.92M | — | |
| Fennec Pharmaceuticals Inc. | FRX.TO | CA$17.42 | CA$610.87M | — | |
| Arvinas, Inc. | ARVN | $9.39 | $605.85M | 36.1 | — |
Nuvectis Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $799.45M
- P/E
- unprofitable
Pharming Group N.V.
Healthcare / Biotechnology
- Market Cap
- $794.84M
- P/E
- 80.2
Monopar Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $789.08M
- P/E
- unprofitable
Aura Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $784.01M
- P/E
- unprofitable
First Tracks Biotherapeutics Inc
Healthcare / Biotechnology
- Market Cap
- $782.20M
Varex Imaging Corporation
Healthcare / Medical Devices
- Market Cap
- $780.16M
- P/E
- 34.9
AgomAb Therapeutics NV
Healthcare / Biotechnology
- Market Cap
- $777.13M
- P/E
- unprofitable
Crescent Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $775.63M
- P/E
- unprofitable
Neurogene Inc.
Healthcare / Biotechnology
- Market Cap
- $772.44M
- P/E
- unprofitable
Phathom Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $768.56M
- P/E
- unprofitable
Assembly Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $745.20M
- P/E
- 29.3
Verastem, Inc.
Healthcare / Biotechnology
- Market Cap
- $742.62M
- P/E
- unprofitable
Zevra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $736.36M
- P/E
- 13.3
Collegium Pharmaceutical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $729.41M
- P/E
- 18.5
Gyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $727.39M
- P/E
- unprofitable
GMR Solutions Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $727.13M
- P/E
- unprofitable
Akso Health Group
Healthcare / Medical Distribution
- Market Cap
- $726.49M
- P/E
- unprofitable
BridgeBio Oncology Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $719.96M
- P/E
- unprofitable
Astria Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $718.13M
- P/E
- unprofitable
XOMA Royalty Corp
Healthcare / Biotechnology
- Market Cap
- $710.16M
- P/E
- 25.6
Enhabit Inc
Healthcare / Medical Care Facilities
- Market Cap
- $706.91M
- P/E
- unprofitable
Ironwood Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $703.92M
- P/E
- 5.4
SOPHiA GENETICS SA
Healthcare / Health Information Services
- Market Cap
- $688.68M
- P/E
- unprofitable
SS Innovations International, Inc.
Healthcare / Medical Devices
- Market Cap
- $683.31M
- P/E
- unprofitable
Shattuck Labs, Inc.
Healthcare / Biotechnology
- Market Cap
- $681.47M
- P/E
- unprofitable
Allogene Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $680.62M
- P/E
- unprofitable
Sagimet Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $680.02M
- P/E
- unprofitable
Phreesia, Inc.
Healthcare / Health Information Services
- Market Cap
- $679.06M
- P/E
- 60.8
Oculis Holding AG
Healthcare / Biotechnology
- Market Cap
- $675.78M
- P/E
- unprofitable
Prime Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.09M
- P/E
- unprofitable
Aquestive Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $670.23M
- P/E
- unprofitable
MiMedx Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $666.13M
- P/E
- 114.3
Altimmune, Inc.
Healthcare / Biotechnology
- Market Cap
- $665.25M
- P/E
- unprofitable
Evotec SE
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $661.02M
- P/E
- unprofitable
CorMedix Inc.
Healthcare / Biotechnology
- Market Cap
- $657.07M
- P/E
- 3.9
Valneva SE
Healthcare / Biotechnology
- Market Cap
- $653.33M
- P/E
- unprofitable
Claritev Corporation
Healthcare / Health Information Services
- Market Cap
- $651.29M
- P/E
- unprofitable
Canopy Growth Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$642.01M
- P/E
- unprofitable
BlossomHill Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $640.08M
- P/E
- unprofitable
Bright Minds Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $639.35M
- P/E
- unprofitable
MapLight Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $638.62M
- P/E
- unprofitable
OmniAb, Inc.
Healthcare / Biotechnology
- Market Cap
- $629.54M
- P/E
- unprofitable
Contineum Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $628.27M
- P/E
- unprofitable
AngioDynamics, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $628.25M
- P/E
- unprofitable
kneat.com Inc
Healthcare / Health Information Services
- Market Cap
- CA$627.72M
- P/E
- unprofitable
Tilray Brands, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $619.11M
- P/E
- unprofitable
Evolus, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $614.27M
- P/E
- unprofitable
Cytek Biosciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $610.92M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- CA$610.87M
- P/E
- unprofitable
Arvinas, Inc.
Healthcare / Biotechnology
- Market Cap
- $605.85M
- P/E
- 36.1
Showing 451–500 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.